glp-1 receptor agonist atrial fibrillation risk use cuts regardless of weight loss Abstract 4368472: Glucagon-Like Peptide 1
Description
A novel approach using orally absorbable peptidyl and non-peptidyl agonists is paving the way toward a new era of GLP-1 receptor agonist therapy
In summary, there are evidence, that treatment with GLP-1RAs may prove useful in the treatment of depressive disorders, however, the number of reliable clinical reports concerning this matter remains very low at this point
NSCs, neural stem cells
10.1007/s00125-003-1103-y
10.1056/NEJMoa1603827 54 MarsoS
A practical guide to statistical power and sample size calculations in R
